J Clin Oncol 2017 Dec 8
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
Related Questions
Is there data to support every 3 week dosage v. weekly?
New answer by Radiation Oncologist at USC Keck School of Medicine (May 30, 2020)
@Nabil F. Saba just presented at the ASCO H&N highlights session that weekly cisplatin 40mg/m2 is now considered a standard of care, at least in the post-op high risk sett...
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice...
New comment by Radiation Oncologist at University of Michigan ( July 7, 2022)
Agree with Dr. @Gary V. Walker regarding the randomized Tata Memorial Docetaxel study, which reported that RT-docetaxel had a significant advantage over RT alone in patie...
For example pT4 and PNI, do you target the neck after a negative neck dissection?
New answer by Radiation Oncologist at University of Michigan (April 5, 2022)
Despite negative margins and pN0, the risk of LRR in this pT4 patient is high, regardless of whether or not the number of dissected nodes was adequate. Moreover, the chance of...